The Gross Margin of China Regenerative Medicine International Ltd (8158.HK) is 63.62%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2023-12-31 | 63.62% |
| 2022-12-31 | 16.24% |
| 2021-12-31 | 23.94% |
| 2020-12-31 | 22.95% |
| 2019-12-31 | 23.74% |
| 2018-12-31 | 37.02% |
| 2017-12-31 | 29.24% |
| 2017-04-30 | 38.52% |
| 2016-04-30 | 66.09% |
| 2015-04-30 | 49.20% |